Danaher and Sartorius AG are leading players in Label-free Detection Market

 Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies.

The global Label-free detection market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593

Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US).

Danaher (US) is a leading player in the label-free detection market. The company strategically focuses on achieving significant growth in existing and new business segments by accelerating its R&D activities to develop innovative products. It also focuses on strengthening its position in key markets by expanding its product offerings. For instance, in 2018, the company introduced Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system that enables automation of over 4500 drug candidate–disease target binding experiments in one run. With its strong portfolio of label-free detection products, the company is likely to maintain its leading position in this market.

Get 10% Customization on this Research Report:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593

Sartorius AG is another leading player in the label-free detection market. The company entered into the label-free detection market with its recent acquisition of ForteBio, which is a global leader in this market. The company focuses on continuous innovation and product development to sustain its leading position. For instance, in 2019, ForteBio introduced a new high precision Streptavidin 2.0 (SAX2) biosensor for the Octet platform. The SAX2 biosensor minimizes variability from consumables and is controlled to meet the most stringent assay precision requirements. Similarly, the company introduced the Sialic Acid (GlyS) kit which enables high throughput glycan screening of crude samples-no purification or digestion steps required. Such innovative product launches will strengthen the company’s position in the label-free detection market.

 

Browse Related Reports:

Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html